Evidence map›Paper›PMID 36407411›Full record

ArticleResources policy2022

Is Tether a safe haven of safe haven amid COVID-19? An assessment against Bitcoin and oil using improved measures of risk.

Khreshna Syuhada, Arief Hakim, Djoko Suprijanto, Intan Muchtadi-Alamsyah, Lukman Arbi

Abstract read
In one paragraph

Article in Resources policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khreshna SyuhadaInstitut Teknologi Bandung, Jalan Ganesa 10, Bandung 40132, Indonesia.
Arief HakimInstitut Teknologi Bandung, Jalan Ganesa 10, Bandung 40132, Indonesia.
Djoko SuprijantoInstitut Teknologi Bandung, Jalan Ganesa 10, Bandung 40132, Indonesia.
Intan Muchtadi-AlamsyahInstitut Teknologi Bandung, Jalan Ganesa 10, Bandung 40132, Indonesia.
Lukman ArbiInstitut Teknologi Bandung, Jalan Ganesa 10, Bandung 40132, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bitcoin is a new speculative investment with extremely volatile movement, thus possibly failing to act as a safe haven for crude oil when the price of this energy commodity plummeted following the global outbreak of COVID-19. Meanwhile, Tether is designed to behave similarly to the US dollar with stable fluctuation. In this study, we assessed their safe-haven properties in terms of risk reduction opportunities by proposing an improved version of Value-at-Risk (VaR) and Expected Shortfall (ES). Using vine copula-based AR-GJR-GARCH models, we demonstrated that Bitcoin exhibited inconsistent risk reduction capability for oil, particularly before COVID-19. When adding Tether into a portfolio containing oil and Bitcoin, the risk reduction was achieved for any portfolio allocation and was more pronounced amid the COVID-19 period. This suggests that Tether consistently served strong support for Bitcoin to protect oil investors against extreme risk and received a significant impact from the COVID-19 outbreak. However, the consistent safe-haven functionality of Tether was not as good as that of the US dollar in most cases, and this implied the vanishing of its stability. These results were robust when considering another asymmetric volatility model and another dependence model. Furthermore, the proposed improved VaR and ES forecasts outperformed their corresponding unimproved version in quantifying portfolio risk and therefore provided a more accurate assessment of safe-haven roles.

Indexed as

COVID-19Crude oilCryptocurrencyExpected ShortfallStablecoinValue-at-Risk

Identifiers

PMID36407411
PMCPMC9663749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.